http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35850539
Outgoing Links
Predicate
Object
contentType
Journal Article
endingPage
3975
issn
1943-8141
issueIdentifier
6
pageRange
3960-3975
publicationName
American journal of translational research
startingPage
3960
bibliographicCitation
Wang J, Zhou Y, Yang Y, Wu Z. The expression panel of CXCL9, GBP5, and IFNG is a potential pan-cancer biomarker to predict immunotherapy response. Am J Transl Res. 2023;15(6):3960–75. PMID: 37434847; PMCID: PMC10331666.
creator
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87516d521f3f59fc5ea76681c0a9764c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b6d9854e7c34a46f6e4e769ca9a6dcc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_37477a35544b67a06b5886b2a8226c94
date
2023
identifier
https://pubmed.ncbi.nlm.nih.gov/PMC10331666
https://pubmed.ncbi.nlm.nih.gov/37434847
isPartOf
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/35651
https://portal.issn.org/resource/ISSN/1943-8141
language
English
source
https://pubmed.ncbi.nlm.nih.gov/
title
The expression panel of CXCL9, GBP5, and IFNG is a potential pan-cancer biomarker to predict immunotherapy response
discussesAsDerivedByTextMining
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7173
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7812
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
Total number of triples:
24
.